The protective role of protein p38 gamma

February 15, 2017 0

A study published last November in Science magazine has changed our understanding of the molecular cascade that triggers Alzheimer's disease. A team from the New…

Two leading drugs in phase III clinical trial

February 6, 2017 0

  Several pharmaceutical companies are currently developing drugs that target Alzheimer's disease. Developping a new drug takes years, and until now, no therapeutic has been…

Statins could reduce the risk of developping Alzheimer’s disease

January 30, 2017 0

According to a recent epidemiological study, the regular use of statins may reduce the odds of developing Alzheimer's disease, but only if the patient takes…

Amyloid plaques do not always correlate with Alzheimer’s disease

January 23, 2017 0

  Alzheimer's disease has been associated for over 100 years with two different types of brain lesions, the beta-amyloid plaques and the tau tangles, both…


Merck halts late-stage trial of promising Alzheimer’s drug

February 15, 2017 0

Merck confirmed today that it will not pursue its EPOCH study, one of its two late-stage trials associated with its